Data Analyst
Platform ScienceFull Time
Junior (1 to 2 years)
Employment Type: Regular, Full-Time Employee
Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With our purified, high-precision investigational cell therapies, we hope to not only replace patients' blood and immune systems with healthy ones but also restore their lives.
The Analyst, Data & Business Intelligence will play a critical role in supporting Orca Bio’s commercial launch and ongoing business performance. This role will own the design, development, and deployment of data reporting infrastructure, field analytics dashboards, and performance measurement tools. The ideal candidate is highly analytical, detail-oriented, and thrives at the intersection of data, systems, and commercial execution. This position works closely with the Forecasting, Sales Operations, Case Management, and Market Access teams to ensure actionable insights are delivered across the organization.
More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks.
The anticipated annual salary range for this job is based on prior experience in the role/industry, education, location, internal equity, and other job-related factors as permitted by law. For remote-based positions, the salary range may be adjusted based on geographic location.
Develops and commercializes cell therapies
Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.